Tokyo - Delayed Quote • JPY
Pharma Foods International Co., Ltd. (2929.T)
At close: 3:15 PM GMT+9
Breakdown
TTM
7/31/2023
7/31/2022
7/31/2021
7/31/2020
Total Revenue
65,081,000.00
68,572,000.00
60,185,000.00
46,752,000.00
15,353,000.00
Cost of Revenue
13,088,000.00
13,293,000.00
12,077,000.00
7,027,000.00
3,178,000.00
Gross Profit
51,994,000.00
55,279,000.00
48,108,000.00
39,724,000.00
12,175,000.00
Operating Expense
45,962,000.00
51,667,000.00
47,026,000.00
34,049,000.00
11,433,000.00
Operating Income
6,032,000.00
3,612,000.00
1,082,000.00
5,675,000.00
742,000.00
Net Non Operating Interest Income Expense
-51,000.00
-47,000.00
-24,000.00
-9,000.00
-4,000.00
Pretax Income
5,996,000.00
3,542,000.00
1,423,000.00
5,765,000.00
848,000.00
Tax Provision
1,233,000.00
462,000.00
1,797,000.00
1,924,000.00
157,000.00
Net Income Common Stockholders
4,763,000.00
3,081,000.00
-374,000.00
3,841,000.00
690,000.00
Diluted NI Available to Com Stockholders
4,763,000.00
3,081,000.00
-374,000.00
3,841,000.00
690,000.00
Basic EPS
165.00
106.70
-12.89
132.21
23.79
Diluted EPS
165.00
106.70
-12.89
132.14
23.78
Basic Average Shares
28,825.00
28,876.51
29,013.83
29,053.37
29,039.77
Diluted Average Shares
28,825.00
28,876.51
29,013.83
29,067.66
29,039.77
Total Operating Income as Reported
6,028,000.00
3,610,000.00
1,080,000.00
5,673,000.00
740,000.00
Total Expenses
59,050,000.00
64,960,000.00
59,103,000.00
41,076,000.00
14,611,000.00
Net Income from Continuing & Discontinued Operation
4,763,000.00
3,081,000.00
-374,000.00
3,841,000.00
690,000.00
Normalized Income
4,805,895.60
3,134,878.00
-495,344.00
3,841,666.00
641,160.00
Interest Income
1,000.00
1,000.00
2,000.00
3,000.00
4,000.00
Interest Expense
52,000.00
48,000.00
26,000.00
12,000.00
8,000.00
Net Interest Income
-51,000.00
-47,000.00
-24,000.00
-9,000.00
-4,000.00
EBIT
6,048,000.00
3,590,000.00
1,449,000.00
5,777,000.00
856,000.00
EBITDA
6,654,000.00
4,136,000.00
1,969,000.00
5,958,000.00
1,007,000.00
Reconciled Cost of Revenue
13,088,000.00
13,293,000.00
12,077,000.00
7,027,000.00
3,178,000.00
Reconciled Depreciation
606,000.00
546,000.00
520,000.00
181,000.00
151,000.00
Net Income from Continuing Operation Net Minority Interest
4,763,000.00
3,081,000.00
-374,000.00
3,841,000.00
690,000.00
Total Unusual Items Excluding Goodwill
-54,000.00
-62,000.00
158,000.00
-1,000.00
60,000.00
Total Unusual Items
-54,000.00
-62,000.00
158,000.00
-1,000.00
60,000.00
Normalized EBITDA
6,708,000.00
4,198,000.00
1,811,000.00
5,959,000.00
947,000.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-11,104.40
-8,122.00
36,656.00
-334.00
11,160.00
7/31/2020 - 6/12/2006
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade